Exact Sciences
Madison, Wisconsin, 53719, United States
NCT Number: NCT04395391
The primary objective is to determine the usability of the SARS-CoV-2 Specimen Collection Materials for at-home collection and mailing of sample to the testing laboratory.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Madison, Wisconsin, 53719, United States
This study is a prospective observational human factors usability study designed to evaluate the Instructions For Use (IFU) in the SARS-CoV-2 Specimen Collection Materials based on the successful completion of self-collection of a nasal swab sample, which includes a valid SARS-CoV-2 test result.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Determine usability of study materials and kit
Time frame: Subjects are assessed at enrollment
The percent of samples from the fully enrolled cohort to return a valid SARS-CoV-2 test result (positive, not detected, or inconclusive)
Exact Sciences Corporation
Industry
Usability Study of Home Collection and Mailing With SARS-CoV-2 Test Specimen Collection Materials (2020-06)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06795880
COVID-19, Coronaviridae Infections
İzmit, Kocaeli, Turkey (Türkiye)
View Trial DetailsNCT07758296
Adherence Interventions, Behavior
Columbia, South Carolina, United States
View Trial DetailsNCT07758309
Adherence Interventions, Behavior
Columbia, South Carolina, United States
View Trial DetailsNCT04481633
COVID-19, Coronaviridae Infections
Limoges, France
View Trial Details